Covered recipient · General Payments record
STELLA LAI
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$5,272.72
- Reported across 295 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $704.54 | 35 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $397.00 | 21 |
| Neurelis, Inc. | $54.44 | 2 |
| PFIZER INC. | $54.14 | 3 |
| Teva Pharmaceuticals USA, Inc. | $45.73 | 2 |
| SK Life Science, Inc. | $37.49 | 2 |
| Neurocrine BioSciences, Inc. | $37.14 | 1 |
| Amneal Pharmaceuticals LLC | $36.93 | 2 |
| Sumitomo Pharma America, Inc. | $25.17 | 1 |
| UCB, Inc. | $16.50 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.93 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104129358 | CMS |
| ABBVIE INC. | $32.04 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104129360 | CMS |
| ABBVIE INC. | $6.35 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104129362 | CMS |
| ABBVIE INC. | $6.35 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104129364 | CMS |
| ABBVIE INC. | $19.00 | 06/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104129366 | CMS |
| ABBVIE INC. | $22.87 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104129368 | CMS |
| ABBVIE INC. | $22.89 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104129370 | CMS |
| ABBVIE INC. | $25.73 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104129372 | CMS |
| ABBVIE INC. | $13.83 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104129374 | CMS |
| ABBVIE INC. | $12.90 | 09/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104129376 | CMS |
| ABBVIE INC. | $31.18 | 09/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104129378 | CMS |
| ABBVIE INC. | $15.61 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104129380 | CMS |
| ABBVIE INC. | $14.22 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104129382 | CMS |
| ABBVIE INC. | $12.09 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104129384 | CMS |
| ABBVIE INC. | $14.96 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104129386 | CMS |
| ABBVIE INC. | $27.33 | 11/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104129388 | CMS |
| ABBVIE INC. | $31.37 | 11/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104129390 | CMS |
| ABBVIE INC. | $33.39 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104129392 | CMS |
| ABBVIE INC. | $12.04 | 11/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104129394 | CMS |
| ABBVIE INC. | $13.23 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104129396 | CMS |
| ABBVIE INC. | $14.69 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104129398 | CMS |
| Amneal Pharmaceuticals LLC | $19.76 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139192514 | CMS |
| Amneal Pharmaceuticals LLC | $17.17 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139192516 | CMS |
| Neurelis, Inc. | $17.68 | 01/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145646071 | CMS |
| Neurelis, Inc. | $36.76 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145646073 | CMS |
| Neurocrine Biosciences, Inc. | $37.14 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150817004 | CMS |
| PFIZER INC. | $16.54 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130997302 | CMS |
| PFIZER INC. | $14.97 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131962080 | CMS |
| PFIZER INC. | $22.63 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131150784 | CMS |
| SK Life Science, Inc. | $24.07 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154144048 | CMS |
| SK Life Science, Inc. | $13.42 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154144116 | CMS |
| Sumitomo Pharma America, Inc. | $25.17 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148878518 | CMS |
| Teva Pharmaceuticals USA, Inc. | $25.19 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151612976 | CMS |
| Teva Pharmaceuticals USA, Inc. | $20.54 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151613198 | CMS |
| UCB, Inc. | $16.50 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143459734 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.